Concluding Remarks

Date 28 September 2014
Event ESMO 2014
Session Bayer: Optimizing Treatment Benefits with MKIs: Understanding Who and When to Treat
Topics Cytotoxic agents
Translational Research
Basic Principles in the Management and Treatment (of cancer)
Therapy
Biological therapy
Presenter José Baselga